Primary Graft Failure clinical trials

Explore recruiting primary graft failure clinical trials.

Recruiting primary graft failure studies right now

Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record

Also recruiting in Europe

Primary Graft Failure trials registered in the EU Clinical Trials Information System (CTIS). These are outside the "near me" matcher above - open a study for full details.

An open-label, single-arm, phase 1/2 first-in-human study to assess the safety and efficacy of autologous CD34+ cells transduced with a lentiviral vector encoding the human NCF1 gene (SGX-001) in paediatric and adult patients with chronic granulomatous disease caused by p47phox deficiency

Germany, Spain

Phase I and Phase II (Integrated)- First administration to humans EU CTIS Study details

Primary Graft Failure trials by city

Primary Graft Failure in Toronto Primary Graft Failure in Vancouver Primary Graft Failure in Montreal Primary Graft Failure in Calgary Primary Graft Failure in Edmonton Primary Graft Failure in Ottawa Primary Graft Failure in Winnipeg Primary Graft Failure in Quebec City Primary Graft Failure in Hamilton Primary Graft Failure in Kitchener Primary Graft Failure in London Primary Graft Failure in Halifax Primary Graft Failure in New York Primary Graft Failure in Los Angeles Primary Graft Failure in Chicago Primary Graft Failure in Houston

Other conditions

Obesity Type 2 diabetes Type 1 diabetes Prediabetes Weight loss Metabolic syndrome High cholesterol High triglycerides High blood pressure PCOS Hypothyroidism Thyroid disease Gout Fatty liver disease (NAFLD/NASH) Heart failure Coronary artery disease Atrial fibrillation Stroke Stroke recovery Peripheral artery disease Pulmonary hypertension Deep vein thrombosis Chronic kidney disease Diabetic kidney disease